International Clinical Trial: A Single-Arm Study of QL1706 Combined With DOS as Neoadjuvant Therapy for Locally Advanced Gastric/GEJ Adenocarcinoma

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07828873) titled 'A Single-Arm Study of QL1706 Combined With DOS as Neoadjuvant Therapy for Locally Advanced Gastric/GEJ Adenocarcinoma' on Sept. 9.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: The First Affiliated Hospital of Zhengzhou University

Condition: Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Intervention: Drug: Iparomlimab and Tuvonralimab Injection (QL1706) Drug: Docetaxel Drug: Oxaliplatin Drug: Tegafur-Gimeracil-Oteracil

Recruitment Status: Not recruiting

Pha...